Similarly, Xiong et al. reported that IGF-1R inhibition stabilized the p53 protein in MEFs and therapy treated cancer cells, potentially by inhibiting the AKT and MDM2-dependent degradation pathway described by Mayo and colleagues [51]. Here, TP53 is linked to cancer.